Nateglinide (Starlix) Manufacturing Plant Project Report 2024-2032

About the Report

The Expert Market Research report, titled “Nateglinide (Starlix) Manufacturing Plant Project Report 2024 Edition: Industry Trends, Capital Investment, Price Trends, Manufacturing Process, Raw Materials Requirement, Plant Setup, Operating Cost, and Revenue Statistics,” provides an in-depth and comprehensive examination of the financial and operational aspects of establishing nateglinide (Starlix) plant.

The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.

It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the nateglinide (Starlix) manufacturing process are included, highlighting process optimisation techniques and technological advancements.

The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up a nateglinide (Starlix) plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.

Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the nateglinide (Starlix) industry.

About Nateglinide (Starlix)

Nateglinide (Starlix) is an oral medication used to treat type 2 diabetes by stimulating insulin secretion from the pancreas. It is a meglitinide drug that lowers blood glucose levels, with a faster onset and shorter duration of action compared to sulfonylureas. Nateglinide was approved by the FDA in December 2000. Nateglinide was developed by Novartis and first marketed under the brand name Starlix in 2001. Starlix medicine is usually recommended at a dosage of 120 mg and is consumed orally three times everyday before meals.

Properties of Nateglinide (Starlix)

Nateglinide (Starlix) is a white powder with a molecular weight of 317.43 g/mol, freely soluble in methanol, ethanol, and chloroform, and soluble in ether. It is sparingly soluble in acetonitrile (0.1 mg/mL) and octanol (0.3 mg/mL), and practically insoluble in water (0.03 mg/mL). Nateglinide stimulates insulin secretion from the pancreas, interacting with the ATP-sensitive potassium (K+ATP) channel to depolarise beta cells and increase insulin release, which is glucose-dependent and diminishes at low glucose levels.

Manufacturing Process of Nateglinide (Starlix)

The production and manufacturing process of Nateglinide (Starlix) involves several key steps. First, the raw materials, such as (-)-N-[(trans-4-isopropylcyclohexane) carbonyl]-D-phenylalanine and other inactive ingredients, are procured to ensure high quality. These raw materials are then mixed according to the specified formulation to create a homogeneous mixture.

Next, the mixture undergoes granulation, where it is processed to achieve the desired particle size and flow properties. The granulated mixture is then used to produce tablets of the appropriate size and shape. To enhance the appearance, durability, and ease of swallowing, the tablets are coated. After the coating process, the tablets are packaged, either in bottles or unit-dose packages, properly labelled, and shipped to distribution centers.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Synthesis of Nateglinide (Starlix)

The process of making Nateglinide involves several steps, such as:

1.    Raw Materials

The primary raw materials used in the production of Nateglinide include:

• (R)-Phenylalanine (C9H11NO2)

• 1,3-Benzothiazol-2-ylamine (C7H6N2S)

• Various reagents and solvents (e.g., acetic anhydride, toluene, etc.)

2. Synthesis of Nateglinide

The synthesis of Nateglinide involves the following key steps and chemical reactions:

• (R)-Phenylalanine is first protected by converting it to its N-acyl derivative using acetic anhydride: C9H11NO2 + (CH3CO)2O → C11H13NO3 + CH3COOH

• The N-acyl derivative is then reacted with 1,3-benzothiazol-2-ylamine to form the Nateglinide core structure: C11H13NO3 + C7H6N2S → C16H17N3O3S + H2O

3.    Purification

The crude Nateglinide is then purified through recrystallisation, where the product is dissolved in a suitable solvent and allowed to crystallise. Further purification is achieved using chromatography techniques to remove any remaining impurities. The purified Nateglinide is then dried and collected for further processing.

4.    Formulation

The purified Nateglinide is formulated into tablets or capsules, involving mixing with excipients, granulation, and compression. The final product is then packaged and prepared for distribution.

Applications and Drivers of Nateglinide (Starlix)

The key drivers of the Nateglinide (Starlix) market include the increasing prevalence of type 2 diabetes globally, the need for effective blood glucose management, and the growing demand for convenient oral antidiabetic agents. For example, in the United States, over 34 million people had diabetes in 2021, with type 2 diabetes accounting for most cases.

The market is also driven by the ageing population, sedentary lifestyles, and rising obesity rates, which are major risk factors for developing type 2 diabetes. According to projections by the International Diabetes Federation (IDF), by 2045, approximately 1 in 8 adults worldwide (about 783 million people) will be living with diabetes, with over 90% of them having type 2 diabetes. Nateglinide (Starlix) provides a treatment option that can be taken before meals to help control postprandial hyperglycemia, making it a valuable addition to the antidiabetic drug collection.

Key Features of the Nateglinide (Starlix) Production Cost Report:

This production cost analysis report by Expert Market Research scrutinises the nateglinide (Starlix) manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the nateglinide (Starlix) industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.

The following sections detail the comprehensive scope of the prefeasibility report for a nateglinide (Starlix) production plant:

• Market Dynamics and Trends: This section analyses the prevailing market conditions, growth drivers, and trends impacting the nateglinide (Starlix) industry. It offers a thorough examination of demand fluctuations and projections.

• Geographic Analysis: Detailed insights into the major regions active in nateglinide (Starlix) production and consumption, highlighting regional market specifics and growth potential.

• Key Industry Players: Profiles of leading manufacturers in the nateglinide (Starlix) sector, outlining their market share, strategic positions, and operational strengths.

• Price Fluctuations: Analysis of historical, current, and projected price trends, providing stakeholders with essential pricing intelligence.

• Technical Specifications and Process Description: A detailed overview of the nateglinide (Starlix) production process including the technology used and innovations within the industry.

• Raw Material Requirements and Sourcing: Evaluation of necessary raw materials, their sourcing strategies, and cost implications.

• Utility Requirements and Costs: Detailed analysis of utilities needed to produce nateglinide (Starlix), such as electricity, steam, and process water along with their cost assessments. 

• Labour Force Dynamics: Insights into manpower requirements, including skill specifications and labour cost projections.

• Packaging Needs: Overview of packaging requirements for nateglinide (Starlix) to ensure product integrity and cost efficiency.

• Logistics and Transportation: Examination of transportation needs and logistics planning for distribution and supply chain efficiency.

• Capital and Operating Costs: An in-depth look at investment requirements, including land acquisition and its development cost, civil work costs, construction, machinery procurement, and ongoing operational expenses, such as salaries and wages, plant overheads, tax and insurance as well as packaging, transportation, and administration costs.

• Financial Performance and Profitability Analysis: Projected profit margins and return on investment based on current market and operational parameters.

• Product Pricing Strategy: Recommendations on pricing mechanisms based on industry benchmarks and production costs.

• Environmental Impact and Regulatory Compliance: Analysis of environmental considerations and compliance with local and international regulations.

• Risk Assessment and Mitigation Strategies: Identification of potential risks associated with nateglinide (Starlix) production and strategies to mitigate them.

Key Questions Addressed:

• What are the detailed unit operations for nateglinide (Starlix) production?

• Who are major technology licensors with their process evaluation?

• How are raw materials or catchem procured and what are their cost implications?

• What utilities are essential for production and what will they cost?

• What are the labour requirements and how does this affect operational costs?

• What packaging solutions are optimal for cost and efficiency?

• What logistical arrangements are necessary for efficient product distribution?

• What are the estimated land and construction costs for a new nateglinide (Starlix) plant?

• How can profitability be maximised in the nateglinide (Starlix) market?

• What pricing strategy should be adopted for nateglinide (Starlix) to remain competitive?

This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the nateglinide (Starlix) industry.